Cambridge Investment Research Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,000
Closed -$27K 3191
2021
Q3
$27K Hold
10,000
﹤0.01% 3048
2021
Q2
$28K Hold
10,000
﹤0.01% 3052
2021
Q1
$30K Hold
10,000
﹤0.01% 2830
2020
Q4
$30K Hold
10,000
﹤0.01% 2671
2020
Q3
$32K Hold
10,000
﹤0.01% 2473
2020
Q2
$33K Hold
10,000
﹤0.01% 2396
2020
Q1
$36K Hold
10,000
﹤0.01% 2209
2019
Q4
$52K Hold
10,000
﹤0.01% 2353
2019
Q3
$59K Hold
10,000
﹤0.01% 2266
2019
Q2
$64K Hold
10,000
﹤0.01% 2134
2019
Q1
$58K Hold
10,000
﹤0.01% 2222
2018
Q4
$60K Hold
10,000
﹤0.01% 2077
2018
Q3
$57K Hold
10,000
﹤0.01% 2181
2018
Q2
$61K Hold
10,000
﹤0.01% 2148
2018
Q1
$67K Hold
10,000
﹤0.01% 2083
2017
Q4
$74K Hold
10,000
﹤0.01% 2047
2017
Q3
$71K Hold
10,000
﹤0.01% 1941
2017
Q2
$70K Hold
10,000
﹤0.01% 1870
2017
Q1
$69K Hold
10,000
﹤0.01% 1717
2016
Q4
$55K Hold
10,000
﹤0.01% 1621
2016
Q3
$50K Hold
10,000
﹤0.01% 1700
2016
Q2
$45K Hold
10,000
﹤0.01% 1522
2016
Q1
$45K Hold
10,000
﹤0.01% 1558
2015
Q4
$53K Hold
10,000
﹤0.01% 1529
2015
Q3
$58K Hold
10,000
﹤0.01% 1385
2015
Q2
$72K Hold
10,000
﹤0.01% 1386
2015
Q1
$67K Hold
10,000
﹤0.01% 1362
2014
Q4
$60K Hold
10,000
﹤0.01% 1324
2014
Q3
$49K Hold
10,000
﹤0.01% 1426
2014
Q2
$45K Buy
+10,000
New +$44.7K ﹤0.01% 1312

Other funds holding CPIX

Cambridge Investment Research Advisors's CPIX Position: Q4 2021 in Review

Cambridge Investment Research Advisors sold out of Cumberland Pharmaceuticals (CPIX) in Q4 2021, closing a stake of 10,000 shares — an estimated $27K sold.

Cambridge Investment Research Advisors first reported a position in CPIX in Q2 2014 and held it in 30 quarters. The position peaked at $74K in Q4 2017. 26 funds tracked by Wall St. Rank hold CPIX as of Q4 2021.

  • Cambridge Investment Research Advisors reported no remaining Cumberland Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 10,000 Cumberland Pharmaceuticals shares in Q4 2021, an estimated $27K.
  • Cambridge Investment Research Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2014 and held it in 30 quarters.
  • Cambridge Investment Research Advisors's Cumberland Pharmaceuticals position peaked at $74K in Q4 2017.
  • 26 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q4 2021.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.